E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/1/2010 in the Prospect News PIPE Daily.

New Issue: Dara BioSciences seals $1.72 million private placement of equity units

By Devika Patel

Knoxville, Tenn., March 1 - Dara BioSciences, Inc. settled a $1.72 million private placement of units on Feb. 26, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company sold 3,652,136 units of one common share and one half-share warrant at $0.47 apiece. Each whole warrant is exercisable at $0.47 for five years.

Based in Raleigh, N.C., Dara is a pharmaceutical company that acquires therapeutic molecules and medical technologies.

Issuer:Dara BioSciences, Inc.
Issue:Units of one common share and one half-share warrant
Amount:$1,716,500
Units:3,652,136
Price:$0.47
Warrants:One half-share warrant per unit
Warrant expiration:Five years
Warrant strike price:$0.47
Settlement date:Feb. 26
Stock symbol:Nasdaq: DARA
Stock price:$0.65 at close Feb. 26
Market capitalization:$23.7 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.